Skip to main content
logo
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.70
-1.25 (-4.17%)
At close: Jul 29, 2026

BIONET Therapeutics Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
154.48154.4881.325.37-
Revenue Growth
46.18%89.96%1414.60%--
Gross Profit
61.6561.652.021.8-
Operating Income
-116.45-116.45-99.36-39.26-12.53
Net Income
-97.43-97.43-86.26-37.34-12.52
Earnings Per Share
-1.39-1.39-1.50-2.47-11.43
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
1,0601,0601,215524.3253.97
Total Debt
10.910.9---
Net Cash (Debt)
1,0491,0491,215524.3253.97
Net Cash Growth
-7.38%-13.63%131.67%871.44%-
Net Cash Per Share
14.9914.9921.1534.7449.29

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-57.48-57.48-124.39-34.16-3.47
Capital Expenditures
-81.19-81.19-46.56-12.1-
Free Cash Flow
-138.68-138.68-170.95-46.26-3.47
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
39.91%39.91%2.48%33.49%-
Operating Margin
-75.38%-75.38%-122.19%-731.20%-
Pretax Margin
-63.07%-63.07%-106.07%-695.44%-
Profit Margin
-63.07%-63.07%-106.07%-695.44%-
FCF Margin
-89.77%-89.77%-210.22%-861.52%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
13.9625.4739.99--